Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and we’ll share relevant market report titles for you to explore.
- Forecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depression
IntroductionGeneric erosion, particularly in the US, will contribute to an overall depression market decline from $11.9bn in 2009 to $11.2bn in 2019 across the seven major markets. In this cost-competitive market, new drugs are ...
- Pipeline and Commercial Insight: Alzheimer's Disease - Market cautiously awaits the first generation of disease-modifying therapies
IntroductionCurrent management of Alzheimer’s disease is wholly inadequate, providing only symptomatic benefit to patients in whom the underlying neurodegeneration continues unabated. However, with the launch of the f...
- Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research ... - Stakeholder Opinions: Ovarian Cancer - Approaching the era of molecular targeted therapy
IntroductionDespite advances in the management of the disease, outcomes remain poor for patients with advanced epithelial ovarian cancer. The high level of unmet need, coupled with the large size of the patient population, ...
- Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options
IntroductionDatamonitor forecasts the inflammatory bowel disease market to become increasingly competitive with the anticipated launch of seven new products, spanning five drug classes from 2010 to 2019. These therapies are...
- Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth
IntroductionSmall molecule targeted therapies represent a highly lucrative class of anticancer therapies with 12 drugs currently approved for various tumor types. This promise of high commercial rewards has driven considera...
- Cancer Prostate Cancer Therapy Area Pipeline Report
Life Science Analytics', Prostate Cancer Therapy Area Pipeline Report contains detailed information on the prostate cancer drug pipeline. This report provides insight into the pipeline status of prostate c...
- Cancer Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report
Life Science Analytics', Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report contains detailed information on the colorectal cancer or colon cancer drug pipeline. This report provides insight in...
- Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed
IntroductionEndometriosis is a common yet poorly understood gynecological disease that affects women of reproductive age. Symptoms include severe chronic pelvic pain and infertility. Endometriosis affects over 17 million wo...
- Commercial Insight: Molecular Targeted Cancer Therapies
IntroductionMolecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many...